The Myeloma Beacon

Independent, up-to-date news and information for the multiple myeloma community.
Home page Deutsche Artikel Artículos Españoles

Forums

Discussion about multiple myeloma treatments, stem cell transplants, clinical trials, alternative medicines, supplements, and their benefits and side effects.

Darzalex patent dispute & availability of the drug

by gmarv on Sun Jan 27, 2019 6:35 pm

Does the patent fight going on over Darzalex (see Genmab press release from yesterday) impact the availability of this drug to us patients who are being treated with it?

gmarv
Name: marvin
Who do you know with myeloma?: myself
When were you/they diagnosed?: aug.2012
Age at diagnosis: 57

Re: Darzalex patent dispute & availability of the drug

by Foundry738 on Mon Jan 28, 2019 1:51 pm

I think it is very unlikely that availability will be affected any time soon. As noted in the release, appeals will be happening. This is typical in patent disputes where the losing side keeps appealing until both parties agree to settle. The only time to worry, usually, is when an injunction is issued preventing sale of the patent infringers product. However, occasionally that company will stop of its own accord because it has concluded that it is going to lose and have to give up profits from past and future sales.

Foundry738
Name: Biclonal
Who do you know with myeloma?: Me
When were you/they diagnosed?: 2016
Age at diagnosis: 67

Re: Darzalex patent dispute & availability of the drug

by Ron Harvot on Mon Jan 28, 2019 2:30 pm

"Patents asserted against Janssen Biotech, Inc. & Genmab in the United States have been declared invalid by summary judgment"

The above is the headline from the article you cited. The named companies are the ones responsible for the manufacture and distribution of Darzalex in the US. Since they won, nothing should change.

Ron Harvot
Name: Ron Harvot
Who do you know with myeloma?: Myself
When were you/they diagnosed?: Feb 2009
Age at diagnosis: 56

Re: Darzalex patent dispute & availability of the drug

by gmarv on Tue Jan 29, 2019 10:14 am

Thanks Ron and Foundry. I got lost in the legal jargon.

gmarv
Name: marvin
Who do you know with myeloma?: myself
When were you/they diagnosed?: aug.2012
Age at diagnosis: 57

Re: Darzalex patent dispute & availability of the drug

by Beacon Staff on Fri Feb 01, 2019 8:59 am

Just so that everyone knows, the three companies involved in the Darzalex patent dispute – MorphoSys, Janssen, and Genmab – have agreed to a settlement ending the litigation. Here is the announcement from Genmab regarding the settlement, and here is the related announce­ment from MorphoSys, the company that initiated the lawsuite against Janssen and Genmab.

Many press releases similar to the ones mentioned above can be found in the Beacon's regularly updated archive of myeloma-related press releases.

Beacon Staff


Return to Treatments & Side Effects